Every laboratory program follows one of two structured implementation paths — Hospital-Based or Physician Practice — each designed around the specific regulatory environment, operational context, and clinical objectives of the organization.
All programs are structured to comply with applicable federal and state laws including the Stark Law (42 U.S.C. §1395nn), Anti-Kickback Statute (42 U.S.C. §1320a-7b(b)), and CLIA regulations. Prospective clients are required to consult qualified healthcare legal counsel prior to entering any arrangement.
The two implementation paths share the same six-phase process but differ significantly in regulatory structure, ownership considerations, and operational design.
Designed for hospitals and health systems seeking to expand internal diagnostic capabilities and improve continuity of care across inpatient and outpatient settings. This path addresses the complexities of hospital-scale regulatory requirements, existing infrastructure integration, and multi-site operational coordination.
Our approach for health systems focuses on scalable infrastructure that grows alongside evolving service line demands, including outreach program development that extends laboratory access to affiliated or community-based providers.
Request a hospital feasibility review →Hospital laboratory programs require infrastructure capable of handling system-level throughput across inpatient, outpatient, and affiliated settings.
Health systems frequently seek to extend laboratory services to affiliated physician practices, FQHCs, and community providers through structured outreach programs.
Hospital-based laboratory programs are subject to CMS Conditions of Participation, CLIA requirements, and hospital-specific Stark Law exception analysis.
Hospital programs typically involve larger capital commitments and require multi-departmental approval. Financial modeling is structured to support the internal review and governance process.
Health system laboratory programs require alignment with system governance structures, including finance committee approval, medical staff involvement, and compliance sign-off.
Multi-site health systems require standardized protocols, consistent compliance frameworks, and operational models that function across diverse facility types and geographies.
Designed for physician groups, urgent care centers, and specialty practices seeking to improve access to diagnostic testing within the clinical setting. In-office laboratory capabilities can reduce patient referral friction, support same-day clinical decision-making, and improve the care experience at the point of service.
This path prioritizes rapid turnaround workflows and scalable testing capabilities calibrated to actual patient volume, integrated directly into the clinical visit pathway with minimal disruption to existing practice operations.
Request a practice feasibility review →Physician practice laboratory programs are configured based on the specific volume, specialty, and physical footprint of the practice — from targeted point-of-care testing to comprehensive in-office laboratories.
Workflow structures are designed to integrate testing directly into the clinical encounter, enabling same-visit results that support immediate clinical decision-making without disrupting practice throughput.
Physician practice laboratory programs must qualify under an applicable Stark Law exception. The in-office ancillary services (IOAS) exception is the most commonly applicable exception for this path, but requires satisfaction of specific structural, supervisory, and billing requirements.
Financial modeling accounts for the specific payer composition of each practice, including commercial insurance, Medicare, Medicaid, and self-pay patients. Reimbursement projections are estimates only.
PE-backed physician practice organizations present unique compliance considerations including management services organization (MSO) structures, compensation models, and multi-state operations that require careful legal review before any laboratory arrangement is established.
Physician practice laboratories most commonly operate under a CLIA Certificate of Waiver (for waived testing only) or a Certificate of Compliance or Accreditation for moderate-complexity testing. The appropriate certificate depends on the test menu and is determined during program design.
Each implementation path involves distinct design decisions that shape regulatory structure, operational model, and financial framework.
Hospital & health system considerations
Physician group & clinic considerations
Both implementation paths follow the same structured six-phase process. Each phase builds on the prior, ensuring compliance and feasibility are confirmed before resources are committed.
An objective assessment of patient volume, test mix, payer composition, and operational fit. No program design begins until feasibility is confirmed and no financial commitments are required at this stage.
Development of laboratory structure, test menu, workflow architecture, and compliance pathway. Program design is tailored to the specific practice setting, regulatory environment, and clinical objectives of the organization.
Preparation of cost and operational projections based on market assumptions, patient volume estimates, and program structure. All projections are estimates only and do not constitute guarantees of financial performance.
Support for CLIA certification, CAP readiness, and applicable state-level regulatory requirements. Coordination includes documentation preparation and submission timeline management alongside qualified legal counsel.
Coordination of laboratory equipment selection, installation planning, and integration with EMR, LIS, and LIMS platforms to ensure operational continuity and billing accuracy from day one.
Structured go-live support with post-launch performance review, workflow refinement, and ongoing compliance monitoring to sustain program integrity beyond initial launch.
All timelines are estimates only. Actual durations vary based on organizational readiness, regulatory jurisdiction, and CLIA certification processing timelines.
Initial assessment of operational, clinical, and financial fit. Completed before any program design commitments. No financial obligation required at this stage.
Test menu, workflow architecture, ownership structure, and compliance pathway developed in coordination with legal counsel. Timeline varies with legal review complexity.
Cost and operational projections prepared based on stated assumptions. Presented as estimates only, not guarantees. Concurrent with program design in most cases.
CLIA application, state licensure, and applicable documentation preparation. CLIA processing by CMS typically takes 8–12 weeks after submission and is the primary timeline driver for most programs.
Equipment procurement, installation, EMR/LIS/billing system integration, and pre-launch operational readiness. Often runs concurrently with regulatory coordination.
Go-live support and structured post-launch reviews. Ongoing compliance monitoring continues indefinitely. First formal post-launch review typically occurs 60–90 days after go-live.
Path selection is determined during the feasibility phase based on organizational type, regulatory environment, and operational context — not by preference alone.
Typically the appropriate path when the organization operates as a licensed hospital or health system, employs or contracts with physicians, and seeks to expand diagnostic capabilities across inpatient, outpatient, or affiliated settings.
Typically the appropriate path when the organization is a physician-owned or physician-operated practice, urgent care network, or specialty clinic seeking in-office or near-site diagnostic capabilities at the point of care.
General orientation only. These responses do not constitute legal, financial, or reimbursement advice.
All submissions are strictly confidential. We use your answers to determine program eligibility and prepare a personalized response. Takes approximately 5–7 minutes.